Drug Availability
HPS Pharmacies wish to advise that Phebra is experiencing a supply interruption for Haemorol™ as follows:
Haemorol™ Injection Vial
Oily Phenol 250mg/5mL
ARTG 161711
Normal supplies are expected to resume from mid-March 2020.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Phebra on 1800 720 020.
Drug Availability
HPS Pharmacies wish to advise that Boucher & Muir is anticipating a supply interruption for Primacin® as follows:
Primacin® Tablets
Primaquine 7.5 mg
ARTG 226430
Normal supplies are expected to resume from mid-March 2020.
An alternative brand of primaquine 7.5mg, presented in packs of 200 tablets, is available via the Special Access Scheme (SAS). Please note that SAS alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Boucher & Muir on (02) 9431 6333.
Drug Availability Update
Further to Drug Alert Volume 526, HPS Pharmacies wish to advise that Mylan is continuing to experience a supply interruption for EpiPen® Jr. as follows:
EpiPen® Jr. Auto-Injector
Adrenaline 150 mcg/0.3 mL
ARTG 42980
Supplies of EpiPen® Jr. are currently constrained. Limited stock is expected to be available from 14th February 2020. However, Mylan advises that supply may be intermittent in the near future as supply equilibrium is restored.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Alphapharm on 1800 274 276.
Drug Availability
HPS Pharmacies wish to give notice that there is a short-term supply interruption for amoxicillin & clavulanic acid 400mg + 57mg/5mL suspension as follows:
| Product |
ARTG |
Expected Return Date |
| Augmentin® Duo 400 Suspension |
67352 |
Mid-late February 2020 |
| Curam® Duo 400/57 Suspension |
147109 |
Late April 2020 |
This supply interruption is regional; warehouses in some states may still have limited stock available. Supplies of amoxicillin & clavulanic acid 125mg + 31.25mg/5mL are not affected by this supply interruption.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Product Availability (Western Australia)
HPS Pharmacies wish to give notice that Perrigo is experiencing a supply interruption for Emollient Ointment Sterile as follows:
Emollient Ointment Sterile
Paraffins and wool fat 30g
Normal supplies are expected to resume by 24th February 2020.
Please note that this communication affects Western Australian sites only. Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Perrigo on 1800 805 546 or your pharmacist at HPS Pharmacies.
Drug Availability
HPS Pharmacies wish to give notice that there is a short-term supply interruption for hydroxocobalamin 1000mcg/mL ampoules as follows:
| Product |
ARTG |
Expected Return Date |
| Cobal-B12 |
285067 |
17th February 2020 |
| Hydroxo-B12 |
161606 |
17th February 2020 |
| Neo-B12™ |
121709 |
10th March 2020 |
| Vita-B12 |
172663 |
11th February 2020 |
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies
Drug Availability
HPS Pharmacies wish to give notice that Ferring Pharmaceuticals is experiencing a supply interruption for Fleet® Ready-to-Use Enema as follows:
Fleet® Ready-to-Use Enema
Dibasic Sodium Phosphate Heptahydrate + Monobasic Sodium Phosphate 7g/19g/118mL
ARTG 146795
Normal supplies are expected to resume by the end of February 2020.
Fleet® Ready-to-Use Enema is a saline laxative indicated for the medically-supervised treatment of constipation and as part of a bowel cleansing regimen in preparation for X-ray or endoscopic examination of the colon. Where clinically appropriate, it may be necessary to consider alternative options such as Microlax® enemas (sodium citrate dihydrate, sodium lauryl sulfoacetate, sorbitol).
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Ferring Pharmaceuticals on (02) 8882 4900 or your pharmacist at HPS Pharmacies.
Drug Availability Update
Further to DrugAlert Volume 516, HPS Pharmacies wish to give notice that Pfizer are experiencing a supply interruption for gentamicin ampoules as follows:
DBL™ Gentamicin Injection
Gentamicin (as sulfate) 10mg/1mL
ARTG 16339
Pfizer Gentamicin Injection BP
Gentamicin (as sulfate) 80mg/2mL
ARTG 11376
Normal supplies of DBL™ Gentamicin Injection 10mg/1mL are expected to resume in late June 2020. Pfizer Gentamicin Injection BP 80mg/mL is currently available in packs of 50 only; packs of 10 ampoules are expected to return in late April 2020.
Pfizer has also issued notice of an anticipated supply interruption for the 80mg/2mL ampoules. This product is expected to be out of stock from late May 2020 until late April 2021.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer on 1800 675 229 or your pharmacist at HPS Pharmacies.
Product Availability
HPS Pharmacies wish to give notice that all hand sanitisers (antimicrobial hand rubs) are experiencing a temporary supply interruption. Normal supplies of some products are expected to resume by mid-February 2020, although some products may continue to experience intermittent supply issues.
This temporary supply interruption is due to increased demand following the outbreak of novel coronavirus (2019-nCoV).
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.
Drug Availability
HPS Pharmacies wish to give notice that Mylan Australia is experiencing a supply interruption for ciprofloxacin IV as follows:
Ciprofloxacin Alphapharm Injection
Ciprofloxacin 400mg/200mL
ARTG 154612
Other brands of this product are also experiencing a short-term supply interruption. Ciprofloxacin injection for intravenous infusion is still available in a 200mg/100mL presentation.
Normal supplies of Ciprofloxacin Alphapharm Injection 400mg/200mL are expected to resume by 20th February 2020. Normal supplies of DBL™ Ciprofloxacin Injection for Intravenous Infusion 400mg/200ml are expected to resume by 10th February 2020.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Mylan Australia on 1800 274 276 or your pharmacist at HPS Pharmacies.
